GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hyuga Primary Care Co Ltd (TSE:7133) » Definitions » Research & Development

Hyuga Primary Care Co (TSE:7133) Research & Development : 円0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hyuga Primary Care Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Hyuga Primary Care Co's Research & Development for the three months ended in Sep. 2024 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was 円0 Mil.

Hyuga Primary Care Co Research & Development Historical Data

The historical data trend for Hyuga Primary Care Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyuga Primary Care Co Research & Development Chart

Hyuga Primary Care Co Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Research & Development
- - - - -

Hyuga Primary Care Co Quarterly Data
Mar20 Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hyuga Primary Care Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hyuga Primary Care Co  (TSE:7133) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Hyuga Primary Care Co Research & Development Related Terms

Thank you for viewing the detailed overview of Hyuga Primary Care Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyuga Primary Care Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hyuga Primary Care Co Ltd (TSE:7133) » Definitions » Research & Development
Comparable Companies
TSE:7061 TSE:2372 TSE:2374 TSE:2373 TSE:9218 TSE:8769 TSE:6059 TSE:6034 TSE:7091 TSE:7097 HCA SAU:4013 SZSE:300015 HKSE:06618 XTER:FRE BKK:BDMS XKLS:5225 BSP:RDOR3 XTER:FME UHS
Traded in Other Exchanges
N/A
Address
2-2-1 Kasugabaru Kitamachi, Fukuoka Prefecture, Kasuga, JPN
Website
https://www.hyuga-primary.care
Hyuga Primary Care Co Ltd is engaged in operation of special nursing homes for the elderly, group homes, paid nursing homes with nursing care, residential area-type paid nursing homes, elderly housing with services, and small-scale multifunctional home care.

Hyuga Primary Care Co Headlines

No Headlines